Vivid Seats Inc.
SEATNasdaqCIK 1856031Consumer discretionaryFiscal year ends Dec 31
Reports and events: 82 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-430446 |
| 2026-08-0410:58 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-331507 |
| 2026-08-0410:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331453 |
| 2026-06-1520:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-271103 |
| 2026-05-0510:42 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-204975 |
| 2026-05-0510:39 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-018995 |
| 2026-04-2720:15 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001140361-26-017103 |
| 2026-03-1210:53 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-103023 |
| 2026-03-1210:40 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-103009 |
| 2026-01-2021:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-016594 |
| 2025-12-3021:15 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001193125-25-337122 |
| 2025-11-0722:02 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-25-272549 |
| 2025-11-0611:36 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-267993 |
| 2025-11-0611:36 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-267994 |
| 2025-10-2320:15 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-039086 |
| 2025-10-2011:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-038568 |
| 2025-08-0510:53 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102376 |
| 2025-08-0510:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102372 |
| 2025-07-2520:16 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-027332 |
| 2025-07-1120:53 ET | DEF 14A | Proxy statementPeriod 2025-07-21 | 0001140361-25-025657 |
| 2025-06-0920:15 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-021949 |
| 2025-05-0610:37 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-063944 |
| 2025-05-0610:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063942 |
| 2025-04-2120:15 ET | DEF 14A | Proxy statementPeriod 2025-06-03 | 0001140361-25-014731 |
| 2025-03-1323:36 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-038228 |
| 2025-03-1210:39 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-037612 |
| 2025-03-1210:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-037611 |
| 2025-02-1121:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-25-003838 |
| 2024-11-0712:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122768 |
| 2024-11-0711:35 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-122751 |
| 2024-10-2420:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-24-044118 |
| 2024-08-0611:13 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091203 |
| 2024-08-0611:08 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-091202 |
| 2024-06-2020:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-030734 |
| 2024-06-1020:15 ET | 8-K | 5.07 Shareholder vote results | 0001140361-24-029568 |
| 2024-05-0711:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053932 |
| 2024-05-0711:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053927 |
| 2024-04-2420:15 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001140361-24-021721 |
| 2024-03-0800:21 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-028243 |
| 2024-03-0511:36 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-025361 |
| 2024-02-0921:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-006725 |
| 2024-01-0921:15 ET | DEF 14A | Proxy statementPeriod 2024-02-05 | 0001140361-24-001524 |
| 2023-12-1322:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-294440 |
| 2023-12-1221:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-293372 |
| 2023-12-0511:12 ET | S-1 | Registration statement | 0001193125-23-288789 |
| 2023-12-0511:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-23-288781 |
| 2023-11-0711:23 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-059732 |
| 2023-11-0711:18 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-059730 |
| 2023-08-0810:33 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039327 |
| 2023-08-0810:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039314 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.